Reminder: Login to access new features and members-only content!

Register to be a member of our community. Its easy!

Register a new account

Already a member?

Log In here!

Donate

Did you find our content interesting or helpful? Help support the IPFD enhance health, well-being and welfare for dogs everywhere.

Jump to content
International Partnership for Dogs Calls for Collective Actions for Health and Welfare of Pedigree Dogs ×
International Partnership for Dogs - Enhancing Dog Health, Well-Being, and Welfare - Join Us
Search In
  • More options...
Find results that contain...
Find results in...

Embark

HGTD Leadership Sponsor Test Discovery- GTP In House Testing ISO Accredited/LAB Out Sourced Testing Any Patents Held Sponsor

General Information

Name
Embark
Data Up to Date
19-May
GTP Code
Embark
URL
https://embarkvet.com
Email
howdy@embarkvet.com
Telephone
1-224-236-2275
Address
77 Summer St Ste 502
City
Boston
State
MA
Zip Code/ Postal Code
78701
Participant Since:
2017
Subsidiary Company

People

Staff Counts
25
Lab/Company Director
Ryan Boyko, CEO
Lab/Company Director Profile
https://www.linkedin.com/in/ryan-boyko-70639150/
Lead Scientist/ Geneticist
Adam Boyko, PhD, CSO
Lead Scientist/ Geneticist Profile
https://www.linkedin.com/in/adam-boyko-53706713/
Lead Veterinarian
Erin Chu, DVM, PhD, Senior Veterinary Geneticist
Lead Veterinarian Profile
https://www.linkedin.com/in/erintchu/
Description of Lab Tech Qualifications
Illumina criteria
Licensed veterinarian(s)
Erin Chu, DVM, PhD; Kate Robinson, DVM, DABVP
Other Experts
Scientific Advisory Board ( https://embarkvet.com/our-story )

Quality Indicators - GTP

HGTD Leadership Sponsor
Sponsor
Supporter
Participant
Academic Participant
Non-participant
Year Established
2015
In House Testing
Out Sourced Testing
ISO Accredited/ GTP
ISO Accredited/LAB
ISO Accredited/tests
Number of Tests with ISO/ details
Specifc Tests=0; General accreditation 200+
ISO Info
Embark laboratory ISO 13485:2003; out-sourced laboratory Illumina is a 9001 accredited business
ISO Comments
ISO 13485:2003 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services. 
Other Recognized Accreditation
Lab SOP details
Illumina FTS SOP
ISAG Parentage Panel Used
No
Other Parentage Testing
Other Parentage Testing Details
Based on 200,000+ SNP markers
Out Sourced Labs More Info
Illumina; see https://www.illumina.com/services/microarray-services.html ; https://www.illumina.com/content/dam/illumina-marketing/documents/services/illumina-professional-care-services-data-sheet-070-2016-005.pdf

Quality Indicators - Procedures/ Services

Sample collected by - GTP specific
Owner
Sample Identification
Unique identifier composed of tranche, barcode and array location
Animal ID/ Sample Submission
Unique swab ID
Animal ID/ by GTP
Unique animal handle
Test Result information
Demo dog results: https://embarkvet.com/dog/harley
Test results provided to
Client
Faults Protocol Details
Complimentary Sanger sequencing of specific test results
Results Query Protocol
Inquiries handled on a case-by-case basis
Laboratory Mishandling Protocol
Quality Assurance and Issue Resolution
Probes undergo stringent quality control and assurance; mutations queried multiple times to ensure replicable results; questionable or concerning results are followed up with Sanger sequencing
Contact for Queries
AD@illumina.com
Breeding Advice
Advice Details
Complimentary. Team of veterinary geneticists and breeder specialists to address any questions

Research

Test Discovery- GTP
Test Discovery Details
Data science in house. Wet lab outsourced for the time being.
Ethics Details
N/A
Test Development In-House
Test Development More Info
Candidate probes designed by science team, QC at Ililumina
Any Patents Held
Details on Patents/Licenses Issued
A Boyko, J Hayward. US 20150344959 A1; "Compositions and methods for genotyping canines "
Research Collaborator
Doberman Diversity Project
Refereed Publications list
In preparation

Phenes

Achromatopsia 2
Achromatopsia (cone degeneration, hemeralopia), GSPT
Alpha Fucosidosis
Ataxia, Cerebellar, Neonatal, GRM1-related
Ataxia, Spinocerebellar, CAPN1-related
Benign Familial Juvenile Epilepsy
Breed/Type/Variety Identification
Canine Cyclic Neutropenia (Grey Collie Syndrome)
Canine Leukocyte Adhesion Deficiency (CLAD)
Canine Multifocal Retinopathy 1 (cmr1)
Canine Multifocal Retinopathy 2 (cmr2)
Canine Multifocal Retinopathy 3 (cmr3)
Centronuclear Myopathy
Cerebellar Ataxia
Collie Eye Anomaly (CEA/CH)
Congenital Hypothyroidism
Congenital Stationary Night Blindness (CSNB)
Copper Toxicosis, COMMD1 Type
Curly Coat Dry Eye (CKCSID)
Cystinuria Type I-A
Cystinuria Type II-A
Cystinuria Type II-B
Dwarfism, Pituitary
Early Onset Adult Deafness (EOAD)
Episodic Falling
Exercise-Induced Collapse / EIC
Factor VII Deficiency
Fanconi Syndrome
Genetic Diversity - genetic coefficent of inbreeding (gCOI)
Globoid Cell Leukodystrophy
Glycogen Storage Disease Type II (GSD II)
Glycogen Storage Disease Type III (GSD III)
Glycogen Storage Disease VII (GSD VII)
GM1 Gangliosidosis
GM2 Gangliosidosis Type I (B Variant)
Hereditary Footpad Hyperkeratosis
Hyperekplexia
Hyperuricosuria and Hyperuricemia (HUU)
Hypocatalasia (Acatalasemia)
Imerslund-Grasbeck Syndrome (I-GS), CUBN related
Junctional Epidermolysis Bullosa
Lagotto Storage Disease
Mucopolysaccharidosis Type VII
Multidrug Resistance 1 (MDR1)
Muscular Dystrophy (Duchenne-type, DMD) GRMD
Musladin-Lueke Syndrome
Myotonia Congenita
Narcolepsy
Nasal Parakeratosis
Neonatal Encephalopathy with Seizures
Neuronal Ceroid Lipofuscinosis 10 (NCL10)
Neuronal Ceroid Lipofuscinosis 12 (NCL12)
Neuronal Ceroid Lipofuscinosis 1 (NCL1)
Neuronal Ceroid Lipofuscinosis 2 (NCL2)
Neuronal Ceroid Lipofuscinosis 6 (NCL6)
Neuronal Ceroid Lipofuscinosis 8 (NCL8)
Oculoskeletal Dysplasia 1
Oculoskeletal Dysplasia 2
Osteogenesis Imperfecta
Polyneuropathy, Juvenile-Onset Inherited (LPN1)/ Laryngeal Paralysis
Polyneuropathy - NDRG1 Type (AMPN)
Primary Ciliary Dyskinesia
Primary Hereditary Cataract (PHC)
Primary Lens Luxation (PLL)
Primary Open Angle Glaucoma (POAG) ADAMTS10
Progressive Retinal Atrophy
Progressive Retinal Atrophy Autosomal Dominant (ADPRA)
Progressive Retinal Atrophy, CNGA1
Progressive Retinal Atrophy - CNGB1
Progressive Retinal Atrophy crd
Progressive Retinal Atrophy crd1 (PRA crd1)
Progressive Retinal Atrophy crd3 (PRA crd3)
Progressive Retinal Atrophy generalized (gPRA)
Progressive Retinal Atrophy, GR PRA2
Progressive Retinal Atrophy, PRA1
Progressive Retinal Atrophy (PRA-prcd)
Progressive Retinal Atrophy rcd1a (PRA rcd1a)
Progressive Retinal Atrophy rcd1 (PRA-rcd1)
Progressive Retinal Atrophy rcd2 (PRA-rcd2)
Progressive Retinal Atrophy rcd3 (PRA-rcd3)
Progressive Retinal Atrophy rcd4 (PRA rcd4)
Progressive Retinal Atrophy, Type 3
Progressive Retinal Atrophy X-linked Type 1 (XLPRA)
Pyruvate Dehydrogenase Deficiency
Pyruvate Kinase Deficiency
Trapped Neutrophil Syndrome (TNS)
Von Willebrand Disease I
Von Willebrand Disease II
Von Willebrand Disease III
X-linked Severe Combined Immunodeficiency Disease (XSCID)
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.

  I accept